News

Open Job Positions

Here you can find open job positions from our members and partners. If you also want to see your job offer here just write us a quick message via the contact form.

Open PhD Student Position (65 %, E13) in the Division for Biochemistry of Joint and Connective Tissue Diseases, Orthopedic Department, University Hospital of Ulm

Project: Elucidating the pathomechanisms of compromised fracture healing in osteoporosis: Consequences of mitochondrial dysfunction

Osteoporosis is a major health problem characterized by compromised bone strength and consequent increased risk of fracture and impaired healing capacities. So far, the underlying pathomechanisms are only poorly understood and pharmacologic approaches are limited. Our project aims on further investigation of the molecular pathomechanisms of osteoporosis, in particular cellular aging and mitochondrial dysfunction, and testing of novel therapeutics strategies to improve bone healing after fracture. The project is part of the Collaborative Research Centre 1149 (CRC1149) “Danger response, disturbance factors and regeneration after acute trauma” and will be performed in the group of Dr. Jana Riegger-Koch at the RKU (www.riegger-lab.de).
Activities and responsibilities:
• human/ mouse primary cell culture, differentiation of mesenchymal stem cells
• molecular biological techniques: gene expression analysis, ELISA, WB, …
• histology: fluorescence staining, immunohistochemistry (IHC)
• writing publications and presentation of own results on conferences/ retreats
Qualification profile:
• master degree in biology, molecular medicine or related field of study
• strong motivation to address bio-medical and pathophysiological questions
• experience in cell and molecular biology, and possibly first insight into animal experiments would be an advantage
We offer:
• direct supervision and training in established methods
• close cooperation with other CRC1149 members
• opportunity to join the International Graduate School in Mol. Medicine Ulm
• development your own scientific profile, incl. additional training opportunities
• funding for 4 years (65 %, E13); starting in February 2023
Detailed applications (CV, certificates etc.) should be send until 8th of January to Dr. Jana Riegger-Koch via mail: jana.riegger@uni-ulm.de. For further information download the flyer. Please feel free to contact Dr. Riegger-Koch for further information or visit our homepage www.riegger-lab.de

PhD student positions in the German Research Foundation (DFG) funded Research Unit FOR2722 “ECM biology and musculoskeletal diseases” 

The Research Unit has an open call for 17 PhD student positions to join our network of excellent and passionate scientists located in one of the most vibrant cities in the center of Europe – Cologne. We work on the extracellular matrix (ECM), the complex and highly information-containing molecular network that surrounds cells. The ECM influences most aspects of cellular function by binding to cell surface receptors or modulating growth factor signalling. It is thereby intimately  involved in many forms of inherited or acquired disease.
Join our vivid network on extracellular matrix biology & musculoskeletal diseases and make a difference!
– Work with leading experts on connective tissue diseases, uncover novel molecular pathomechanisms and develop tailored therapies.
– Enjoy a highly interdisciplinary research environment with 18 internationally recognized group leaders from basic science to translational medicine with focus on mechanobiology, systems biology, biochemistry, molecular and developmental biology, human genetics and diseases, clinical translation.
– Interact with groups of our collaborative research network at renowned institutions: The Childrens Hospital & research institutes of the University of Cologne – the German Sport University Cologne – the Max Planck Institute for the Biology of Aging – the Cluster of Excellence CECAD – the Institute for Musculoskeletal Medicine (Münster) – the Dr. Rolf M. Schwiete Research Unit (Frankfurt)

You will benefit from
– Excellent projects that address basic and translational questions in extracellular matrix biology and connective tissue diseases
– Access to advanced imaging/mass spectrometry/genomic & gene editing technologies, disease models (mouse, fish, organoids) and translational approaches (protein targeting & therapeutic antibody development)
– Advanced training, mentoring and networking in a cohort of PhD students entirely dedicated to the extracellular matrix and connective tissue diseases
– Training workshops in extracellular matrix biology and musculoskeletal diseases, high throughput data analysis and clinical aspects of connective tissue diseases
– Soft skills courses (presentation & scientific writing, good scientific conduct)
– Structured PhD programme and thesis advisory committees
– Participation and organization of summer schools, seminar series, annual retreats and international symposia
– Mobility grants for national and international short term lab visits
– Full funding for international and German students, no tuition costs

We invite
highly motivated applicants with an MSc (or equivalent) degree and a strong background in life sciences e.g. biochemistry, molecular medicine, pharmacy, veterinary medicine, medicine and bioengineering.

Apply now and send your application including a letter of motivation, copy of certificates, a CV and names of two references to trine.riemer@uni-koeln.de
For further information download the flyer, visit us on Twitter @DFG_FOR2722 or https://for2722.uni-koeln.de

Doctoral researcher (PhD student) position in the area of rare skeletal diseases

In the research group “Skeletal Pathobiochemistry” at the University Medical Center Hamburg-Eppendorf (UKE) we are interested in the molecular basis of rare genetic diseases affecting bone and cartilage tissues in the early years of life. Our newly funded project aims to explore the molecular pathomechanisms of an ultra-rare, X-linked form of osteogenesis imperfecta. The position is to be filled with 65% (TVöD/VKA E13) of the regular weekly working hours and is to be occupied at the earliest possible date. The position is funded by the German Research Foundation (DFG) for a period of three years.

Contact: Dr. Tatyana Danyukova, Tel.: (040)7410-58780, E-mail: t.danyukova@uke.de

Application should include full CV, academic transcript(s) and/or certificates, a brief statement of your research interests and contact information of 2-3 references. Please send your application as a single PDF file to t.danyukova@uke.de by 20th January 2023 (reference code WS22901).

For more information about our research group, please visit us here visit us here

For more information about the position and how to apply, please visit the UKE career web-page

Post Doctoral Researcher in Lyon

The research group of Catherine Moali in the LBTI (Tissue Biology and Therapeutic Engineering Lab, Lyon, France, https://lbti.ibcp.fr ) is looking for a Post Doctoral Researcher (for minimum of 2 years) to work on the  structure-function analysis of the proteolytic maturation complex of fibrillar collagens. Our keywords : extracellular matrix, collagen, proteases, mechanism, structure, CryoEM.  The project aims to better understand the steps leading from the synthesis of individual procollagen chains to collagen fibrils and would greatly benefit the development of new therapeutic tools targeting fibrotic diseases. Project in collaboration with the OPIC (Oxford Particle Imaging Center) facility in Oxford.

LBTI is a young and dynamic research laboratory located in the heart of Lyon Biodistrict (>5000 people working in life sciences and biomedical research). It offers top-level equipment in biology and a very stimulating scientific environment. Located in the South-East of France, Lyon is the second biggest scientific and economic center in the country and is internationally recognized for its quality of life.

Find out more and apply and download the flyer

Contact: catherine.moali@ibcp.fr

Two junior faculty positions in the area of tissue biology to be based at the Kennedy Institute of Rheumatology, University of Oxford

Following a recent strategic review, tissue biology has been identified as high priority for the Institute and an area for investment from the Kennedy Trust for Rheumatology Research (KTRR). Accordingly, in 2022, in combination with funding from KTRR and Versus Arthritis, we launched a new Tissue Biology Platform, led by Professor Tonia Vincent.

The new faculty members will play a vital role in developing the Tissue Biology Platform by bringing expertise in areas such as the extracellular matrix, tissue niche, stem cell biology, in vitro human organoids and proteomics. Tissues of interest might include, but are not restricted to, bone, cartilage, synovium, endothelium and epithelium. There is a strong translational ethos at the Institute with an emphasis on inflammatory, mechano-inflammatory and fibrotic diseases.

The two positions are distinct, with a senior position “Group Leader in Tissue Biology” most suited to an established scientist wishing to pursue a pure academic track, and “Group Leader (Innovation Investigator Track) in Tissue Biology” which would suit a more junior person where there would be an expectation that 50% of their time was used to help support collaborative activities across the Institute (this could include technology-based expertise).

Links to the two job descriptions with details on how to apply: Group Leader in Tissue Biology and Group Leader (Innovation Investigator Track) in Tissue Biology

We also have funding for a post doc in proteomics to support mass spec analysis across the Institute. This post would suit a recent PhD graduate, or more established PDRA, with hands on experience in proteomic and/or lipidomic analysis.

12 Doctoral Candidate positions – MSCA – “Cellular Homeostasis ANd AGing in Connective TissuE Disorders” (CHANGE) in the framework of the Horizon Europe Marie Curie Doctoral Network

CHANGE is a Marie Sklodowska-Curie Doctoral Network (MSCA-DN) focused on investigating connective tissue (CT) disorders to identify key players in age-related decline in physiological functions to develop therapeutic strategies and identify treatment targets for common diseases and frailty associated with aging. It is part of Horizon EUROPE programme of the European Union and 12 Doctoral Candidates (DC) will be appointed for 36 months each.

CHANGE project – summary

Lifespan has significantly increased but age-related disorders severely limit healthy aging and quality of life, and are a serious burden for the society. Musculoskeletal, cardio- and cerebrovascular failure are hallmarks of physical and cognitive decline in the elderly, but importantly, are also common traits in several early onset hereditary connective tissue disorders.

In CHANGE, 12 young scientists will combine skills in musculoskeletal and vascular developmental and cellular biology and pathobiology related to aging, with expertise in cell culture, animal models, -omics, innovative high-resolution imaging and functional techniques. Exchange of knowledge and multidisciplinary collaboration between these fields of research and partners within the consortium will provide the skills, multidisciplinary knowledge and on-the-job training experience necessary to tackle the main aspects of biology of aging and age-related disorders affecting bone, cartilage, muscle and vasculature.

PhD positions

The consortium consists of partners from academia and industry with excellent scientific qualifications in multiple disciplines. In total, there are 12 open PhD positions for DCs within CHANGE. Each DC will be appointed at one of the consortium partners but secondments and regular meetings will be performed at other partners to ensure multidisciplinary training and close collaboration. An ideal DC candidate will hold a Master’s degree with excellent marks from her/his previous studies and experience in one or more of the relevant broad research fields will be an advantage. Excellent written and oral communication skills in English are essential. The DCs will start their projects between September 2022 and March 2023.

More details here.

To apply for this position, send your CV, motivation letter and at least a reference letter to the following email address: change_project.msca@unipv.it

Please state the DC reference (CHANGE DC number) in the subject line. If you would like to apply for more than one position, please indicate your first and second preference.

Short listed Applicants will be interview by the Trainee Committee.

Obituary

In memory of

Prof. Dr. Dr. h.c. Klaus Kühn

*1.5.1927     † 7.4.2022

 

Klaus Kühn was a pioneer in collagen research with landmark discoveries in the collagen field, who shaped a sustainable extracellular matrix research in Germany and throughout the world. The passionate collagen scientist was fascinated by the collagen tripelhelix and was always a leading, highly motivating figure in the field who encouraged generations of young people to climb apparently unsurmountable summits.

Somehow, it happened that every chair in matrix biology research in Germany came from or went through Klaus Kühn‘s lab. The German Society for Matrix Biology and the worldwide matrix biology community is greatly saddened by the passing of Klaus Kühn.

 

Klaus Kühn had managed to establish an extremely successful international research center while maintaining a kind and collegial atmosphere within the department, welcoming students and scientists from all over the world. This was unique in the highly hierarchical academic structure in Germany at that time. Klaus Kühn was proud to be a typical chemist but he welcomed initiatives to approach connective tissue research from many different angles and he was always very interested in medical issues. He enjoyed scientific discussions as well as playing tennis with the members of his department. There is no doubt that he had a profound influence on our scientific, academic and personal life.

Monique Aumailley and Thomas Krieg

Er hinterlässt uns allen das Bild einer eindrücklichen, großzügigen, immer bescheidenen und liebenswürdigen Forscherpersönlichkeit. Sein Lebenswerk umfasst eine große Zahl von Wissenschaftlern, deren Entwicklung und Karriere er nachhaltig beeinflusst hat, eine zusätzliche Leistung, die alles andere als eine Selbstverständlichkeit ist. Wir alle sind ihm dafür zu Dank verpflichtet.

Peter Bruckner

Er war ein ausgezeichneter Lehrmeister, der wissenschaftliche Expertise mit einer fürsorglichen Menschlichkeit verband. Unvergesslich ist, wie er junge Wissenschaftler in die Wissenschaftsgemeinde der Extrazellulären Matrix integrierte. Der offene Wissenschaftsaustausch und die angenehme Umgebung auf Matrix-Tagungen ist auch sein Verdienst. Für sein prägendes Vorbild, Wissenschaft menschlich zu machen, bin ich ihm sehr dankbar. Ich bewahre ihn in Erinnerung.

Johannes Eble

Klaus Kühn was a pioneer, a titan of collagen research, and an excellent teacher and mentor. His scientific heritage and mentorship left lasting marks on connective tissue research, both in- and outside Germany. Even after his retirement, Klaus Kühn often visited his beloved Max Planck Institute of Biochemistry and always stopped by in my department to talk about the latest breakthroughs in matrix and adhesion research. His visits, discussions, support and advice will always remain in my memory.

Reinhard Fässler

Nicht nur die Wissenschaft, sondern auch viele muntere und warmherzige Treffen hat mich mit Klaus Kühn verbunden. Es sind nicht zuletzt diese Runden in anspruchsvoller Konversation und freundschaftlich, verbindlicher Atmosphäre, die uns in Erinnerung bleiben und die uns deutlich machen, welch menschlicher Verlust der fast gemeinsame Tod von Barbara und Klaus für uns bedeutet.

Verena Gauss-Müller & Peter Müller

I first got to know Klaus Kühn in 1983 when I joined Rupert Timpl´s group in the Kühn department in Martinsried. Later there were many more meetings, in particular at the famous retreats at Schloss Ringberg. Klaus was an outstanding scientist, but also a very kind and supportive mentor. I much appreciated the generosity with which he led his department. He gave us great freedom and a main priority was always the development of his younger coworkers. For this reason many of us stayed as long as ever possible. He became my role model with regard to scientific leadership. I feel deep sorrow.

Mats Paulsson

Klaus Kühn war für uns immer ein Fixpunkt als brillanter, stimulierender und immer neugieriger Wissenschaftler. Es war ein Erlebnis in seiner Abteilung, auch wenn er es einem nicht immer ganz leicht machte. Ein besonderer Mensch der Güte und Menschlichkeit ausstrahlte und dabei versuchte, die nächste Generation zu fordern und das Beste in ihnen zu fördern. In diesem Sinne erfüllt uns der Verlust mit Trauer aber auch menschlicher Dankbarkeit.

Ernst Pöschl & Ulrike Mayer

Ich werde Klaus Kühn als Freund, verständnisvollen Doktorvater, effizienten Institutsleiter und großen Wissenschaftler in Erinnerung behalten, der nicht nur die Wissenschaftsszene in Deutschland entscheidend geprägt hat, sondern auch den nachfolgenden Generationen die Erkenntnis mitgegeben hat, zu welcher Tiefe, Freude und Erfolg koordinierte Forschung im Team führen kann.

Klaus von der Mark

If you also wish to submit a personal obituary contact us.

Publications

2022

Kümper M, Zamek J, Steinkamp J, Pach E, Mauch C, Zigrino P.
Role of MMP3 and fibroblast-MMP14 in skin homeostasis and repair.
23 Sep 2022, https://pubmed.ncbi.nlm.nih.gov/36162272/

Onyeisi JOS, Lopes CC, Götte M.
Role of syndecan-4 in breast cancer pathophysiology.
12 Sep 2022, https://pubmed.ncbi.nlm.nih.gov/36094435/

Kümper M, Steinkamp J, Zigrino P.
Metalloproteinases in dermal homeostasis.
12 Sep 2022, https://pubmed.ncbi.nlm.nih.gov/36094433/

Riegger J, Maurer S, Pulasani S, Brenner RE.
Simvastatin and fluvastatin attenuate trauma-induced cell death and catabolism in human cartilage.
9 Sep 2022, https://pubmed.ncbi.nlm.nih.gov/36159664/

Willenborg S, Injarabian L, Eming SA.
Role of Macrophages in Wound Healing.
30 Aug 2022, https://pubmed.ncbi.nlm.nih.gov/36041784/

Zhang JL, Richetti S, Ramezani T, Welcker D, Lütke S, Pogoda HM, Hatzold J, Zaucke F, Keene DR, Bloch W, Sengle G, Hammerschmidt M.
Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2.
22 Aug 2022, https://pubmed.ncbi.nlm.nih.gov/36007682/

Zhang JL, Richetti S, Ramezani T, Welcker D, Lütke S, Pogoda HM, Hatzold J, Zaucke F, Keene DR, Bloch W, Sengle G, Hammerschmidt M.
Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2.
22 Aug 2022, https://pubmed.ncbi.nlm.nih.gov/36007682/

Wang C, Stöckl S, Li S, Herrmann M, Lukas C, Reinders Y, Sickmann A, Grässel S.
Effects of Extracellular Vesicles from Osteogenic Differentiated Human BMSCs on Osteogenic and Adipogenic Differentiation Capacity of Naïve Human BMSCs.
11 Aug 2022, https://pubmed.ncbi.nlm.nih.gov/36010568/

Ivanova EL, Costa B, Eisemann T, Lohr S, Boskovic P, Eichwald V, Meckler J, Jugold M, Orian-Rousseau V, Peterziel H, Angel P.
CD44 expressed by myeloid cells promotes glioma invasion.
4 Aug 2022, https://pubmed.ncbi.nlm.nih.gov/35992852/

Riecks J, Parnigoni A, Győrffy B, Kiesel L, Passi A, Vigetti D, Götte M.
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer.
29 Jun 2022, https://pubmed.ncbi.nlm.nih.gov/35767191/

Dinesh NEH, Campeau PM, Reinhardt DP.
Fibronectin isoforms in skeletal development and associated disorders.
27 Jun 2022, https://pubmed.ncbi.nlm.nih.gov/35759430/

Tiedemann K, Muthu ML, Reinhardt DP, Komarova SV.
Male Marfan mice are predisposed to high-fat diet-induced obesity, diabetes, and fatty liver.
27 Jun 2022, https://pubmed.ncbi.nlm.nih.gov/35759435/

Becker L, Fischer F, Fleck JL, Harland N, Herkommer A, Stenzl A, Aicher WK, Schenke-Layland K, Marzi J.
Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids.
23 Jun 2022, https://pubmed.ncbi.nlm.nih.gov/35805961/

Wang J, Eming SA, Ding X.
Role of mTOR Signaling Cascade in Epidermal Morphogenesis and Skin Barrier Formation.
19 Jun 2022, https://pubmed.ncbi.nlm.nih.gov/35741452/

Thievessen I, Suhr F, Vergarajauregui S, Böttcher RT, Brixius K, Rosenberger G, Dewald O, Fleischmann BK, Ghanem A, Krüger M, Engel FB, Fabry B, Bloch W, Fässler R.
The focal adhesion protein β-parvin controls cardiomyocyte shape and sarcomere assembly in response to mechanical load.
9 Jun 2022, https://pubmed.ncbi.nlm.nih.gov/35688156/

Wagner N, Rapp AE, Braun S, Ehnert M, Imhof T, Koch M, Jenei-Lanzl Z, Zaucke F, Meurer A.
Generation of Matrix Degradation Products Using an In Vitro MMP Cleavage Assay.
2 Jun 2022, https://pubmed.ncbi.nlm.nih.gov/35682922/

Zhang RM, Tiedemann K, Muthu ML, Dinesh NEH, Komarova S, Ramkhelawon B, Reinhardt DP.
Fibrillin-1-regulated miR-122 has a critical role in thoracic aortic aneurysm formation.
23 May 2022, https://pubmed.ncbi.nlm.nih.gov/35606547/

Esho T, Tufa SF, Kobbe B, Wohl AP, Sengle G, Paulsson M, Keene DR, Wagener R.
Anchoring Cords: A Distinct Suprastructure in the Developing Skin.
22 May 2022, https://pubmed.ncbi.nlm.nih.gov/35613627/

Hillemeyer L, Espinoza-Sanchez NA, Greve B, Hassan N, Chelariu-Raicu A, Kiesel L, Götte M.
The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis.
21 May 2022, https://pubmed.ncbi.nlm.nih.gov/35628603/

Dreier R, Ising T, Ramroth M, Rellmann Y.
Estradiol Inhibits ER Stress-Induced Apoptosis in Chondrocytes and Contributes to a Reduced Osteoarthritic Cartilage Degeneration in Female Mice.
20 May 2022, https://pubmed.ncbi.nlm.nih.gov/35669511/

Schäfer N, Grässel S.
Involvement of complement peptides C3a and C5a in osteoarthritis pathology.
20 May 2022, https://pubmed.ncbi.nlm.nih.gov/35598724/

Caliandro MF, Schmalbein F, Todesca LM, Mörgelin M, Rezaei M, Meißner J, Siepe I, Grosche J, Schwab A, Eble JA.
A redox-dependent thiol-switch and a Ca2+ binding site within the hinge region hierarchically depend on each other in α7β1 integrin regulation.
20 May 2022, https://pubmed.ncbi.nlm.nih.gov/35605898/

D'Arcy C, Zimmermann CC, Espinoza-Sanchez NA, Greve B, Schmidt A, Kiesel L, von Wahlde MK, Götte M.
The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast.
19 May 2022, https://pubmed.ncbi.nlm.nih.gov/35587107/

Marzi J, Munnig Schmidt EC, Brauchle EM, Wissing TB, Bauer H, Serrero A, Söntjens SHM, Bosman AW, Cox MAJ, Smits AIPM, Schenke-Layland K.
Marker-Independent Monitoring of in vitro and in vivo Degradation of Supramolecular Polymers Applied in Cardiovascular in situ Tissue Engineering.
17 May 2022, https://pubmed.ncbi.nlm.nih.gov/35656396/

Urbanczyk M, Zbinden A, Schenke-Layland K.
Organ-specific endothelial cell heterogenicity and its impact on regenerative medicine and biomedical engineering applications.
11 May 2022, https://pubmed.ncbi.nlm.nih.gov/35568103/

Muthu ML, Tiedemann K, Fradette J, Komarova S, Reinhardt DP.
Fibrillin-1 regulates white adipose tissue development, homeostasis, and function.
6 May 2022, https://pubmed.ncbi.nlm.nih.gov/35533973/

Lückgen J, Raqué E, Reiner T, Diederichs S, Richter W
NFκB inhibition to lift the mechano-competence of mesenchymal stromal cell-derived neocartilage toward articular chondrocyte levels
27 Apr 2022, https://pubmed.ncbi.nlm.nih.gov/35477424/

Fromme JE, Zigrino P.
The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance.
26 Apr 2022, https://pubmed.ncbi.nlm.nih.gov/35558554/

Feuerer N, Carvajal Berrio DA, Billing F, Segan S, Weiss M, Rothbauer U, Marzi J, Schenke-Layland K.
Raman Microspectroscopy Identifies Biochemical Activation Fingerprints in THP-1- and PBMC-Derived Macrophages.
25 Apr 2022, https://pubmed.ncbi.nlm.nih.gov/35625726/

Chen NP, Aretz J, Fässler R
CDK1-cyclin-B1-induced kindlin degradation drives focal adhesion disassembly at mitotic entry
25 Apr 2022, https://pubmed.ncbi.nlm.nih.gov/35469017/

Dreiner M, Munk T, Zaucke F, Liphardt AM, Niehoff A
Relationship between different serum cartilage biomarkers in the acute response to running and jumping in healthy male individuals
19 Apr 2022, https://pubmed.ncbi.nlm.nih.gov/35440750/

Przyklenk M, Georgieva VS, Metzen F, Mostert S, Kobbe B, Callewaert B, Sengle G, Brachvogel B, Mecham RP, Paulsson M, Wagener R, Koch M, Schiavinato A
LTBP1 promotes fibrillin incorporation into the extracellular matrix
19 Apr 2022, https://pubmed.ncbi.nlm.nih.gov/35452817/

Martin IM, Nava MM, Wickström SA, Gräter F
ATP allosterically stabilizes integrin-linked kinase for efficient force generation
8 Mar 2022, https://pubmed.ncbi.nlm.nih.gov/35259013/

Strauß T, Greve B, Gabriel M, Achmad N, Schwan D, Espinoza-Sanchez NA, Laganà AS, Kiesel L, Poutanen M, Götte M, Schäfer SD
Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis
5 Mar 2022, https://pubmed.ncbi.nlm.nih.gov/35269992/

Rosendahl AH, Schönborn K, Krieg T
Pathophysiology of systemic sclerosis (scleroderma)
2 Mar 2022, https://pubmed.ncbi.nlm.nih.gov/35234358/

Loustau T, Abou-Faycal C, Erne W, Zur Wiesch PA, Ksouri A, Imhof T, Mörgelin M, Li C, Mathieu M, Salomé N, Crémel G, Dhaouadi S, Bouhaouala-Zahar B, Koch M, Orend G
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO"
26 Feb 2022, https://pubmed.ncbi.nlm.nih.gov/35227929/

Reuten R, Mayorca-Guiliani AE, Erler JT
Matritecture: Mapping the extracellular matrix architecture during health and disease
3 Feb 2022, https://pubmed.ncbi.nlm.nih.gov/35243299/

Hilgers K, Ibrahim SA, Kiesel L, Greve B, Espinoza-Sánchez NA, Götte M
Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
27 Jan 2022, https://pubmed.ncbi.nlm.nih.gov/35155241/

Morcos YAT, Lütke S, Tenbieg A, Hanisch FG, Pryymachuk G, Piekarek N, Hoffmann T, Keller T, Janoschek R, Niehoff A, Zaucke F, Dötsch J, Hucklenbruch-Rother E, Sengle G
Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin
25 Jan 2022, https://pubmed.ncbi.nlm.nih.gov/35079041/

Rösch G, Muschter D, Taheri S, El Bagdadi K, Dorn C, Meurer A, Zaucke F, Schilling AF, Grässel S, Straub RH, Jenei-Lanzl Z
β2-Adrenoceptor Deficiency Results in Increased Calcified Cartilage Thickness and Subchondral Bone Remodeling in Murine Experimental Osteoarthritis
13 Jan 2022, https://pubmed.ncbi.nlm.nih.gov/35095883/

Kahl I, Mense J, Finke C, Boller AL, Lorber C, Győrffy B, Greve B, Götte M, Espinoza-Sánchez NA
The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients
10 Jan 2022, https://pubmed.ncbi.nlm.nih.gov/35014077/

Böttcher RT, Strohmeyer N, Aretz J, Fässler R.
New insights into the phosphorylation of the threonine motif of the β1 integrin cytoplasmic domain
7 Jan 2022, https://pubmed.ncbi.nlm.nih.gov/34996844/

You are interested in collaborating with us or you want more information about DGMB? So just talk to us!